Literature DB >> 4349486

Glucagon release induced by pancreatic nerve stimulation in the dog.

E B Marliss, L Girardier, J Seydoux, C B Wollheim, Y Kanazawa, L Orci, A E Renold, D Porte.   

Abstract

A direct neural role in the regulation of immunoreactive glucagon (IRG) secretion has been investigated during stimulation of mixed autonomic nerves to the pancreas in anesthetized dogs. The responses were evaluated by measurement of blood flow and hormone concentration in the venous effluent from the stimulated region of pancreas. Electrical stimulation of the distal end of the discrete bundles of nerve fibers isolated along the superior pancreaticoduodenal artery was invariably followed by an increase in IRG output. With 10-min periods of nerve stimulation, the integrated response showed that the higher the control glucagon output, the greater was the increment. Atropinization did not influence the response to stimulation. That the preparation behaved in physiologic fashion was confirmed by a fall in IRG output, and a rise in immunoreactive insulin (IRI) output, during hyperglycemia induced by intravenous glucose (0.1 g/kg). The kinetics of this glucose effect on IRG showed characteristics opposite to those of nerve stimulation: the lower the control output, the less the decrement. Furthermore, during the control steady state, blood glucose concentration was tightly correlated with the IRI/IRG molar output ratio, the function relating the two parameters being markedly nonlinear. Injection or primed infusion of glucose diminished the IRG response to simultaneous nerve stimulation. Measurement of IRG was inferred to reflect response of pancreatic glucagon secretion on the basis of the site of sample collection (the superior pancreaticoduodenal vein), the absence of changes in arterial IRG, and similar responses being obtained using an antibody specific for pancreatic glucagon. THESE STUDIES SUPPORT A ROLE FOR THE AUTONOMIC NERVOUS SYSTEM IN THE CONTROL OF GLUCAGON SECRETION: direct nerve stimulation induces glucagon release. Such sympathetic activation may be interpreted as capable of shifting the sensitivity of the A cell to glucose in the direction of higher glycemia for a given glucagon output. The experimental model employed is valid for further studies of regulatory mechanisms of endocrine pancreatic function in vivo.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4349486      PMCID: PMC302381          DOI: 10.1172/JCI107292

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Fine structure of mammalian and avian pancreatic islets with special reference to D cells and nervous elements.

Authors:  S Kobayashi; T Fujita
Journal:  Z Zellforsch Mikrosk Anat       Date:  1969-09-17

2.  The fine structure and innervation of the beta and delta cells in the islet of Langerhans of the cat.

Authors:  P G Legg
Journal:  Z Zellforsch Mikrosk Anat       Date:  1967

3.  Fine structure of nervous elements in the pancreas of some vertebrates.

Authors:  N Watari
Journal:  Z Zellforsch Mikrosk Anat       Date:  1968

4.  Inhibition of insulin release in infants undergoing deep hypothermic cardiovascular surgery.

Authors:  D Baum; D H Dillard; D Porte
Journal:  N Engl J Med       Date:  1968-12-12       Impact factor: 91.245

5.  Portal and peripheral vein immunoreactive insulin concentrations before and after glucose infusion.

Authors:  W G Blackard; N C Nelson
Journal:  Diabetes       Date:  1970-05       Impact factor: 9.461

6.  Effect of blood glucose on glucagon secretion in anesthetized dogs.

Authors:  K D Buchanan; J E Vance; K Dinstl; R H Williams
Journal:  Diabetes       Date:  1969-01       Impact factor: 9.461

7.  Control of pancreatic glucagon secretion by glucose.

Authors:  A Ohneda; E Aguilar-Parada; A M Eisentraut; R H Unger
Journal:  Diabetes       Date:  1969-01       Impact factor: 9.461

8.  [Evolution of hormonal parameters (glucagon, cortisol, growth hormone) and energetic parameters (glucose, fatty acids, free glycerol) in 10 severe cases of diabetic acido-ketosis under treatment].

Authors:  R Assan; G Hautecouverture; S Guillemant; F Dauchy; P Protin; M Derot
Journal:  Pathol Biol (Paris)       Date:  1969-12

9.  Insulin output via the pancreatic vein and plasma insulin response to glucose in dogs.

Authors:  Y Kanazawa; T Kuzuya; T Ide
Journal:  Am J Physiol       Date:  1968-09

10.  Studies of pancreatic alpha cell function in normal and diabetic subjects.

Authors:  R H Unger; E Aguilar-Parada; W A Müller; A M Eisentraut
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808

View more
  30 in total

1.  Stimulatory and inhibitory effects of cyclic AMP on pancreatic glucagon release from monolayer cultures and the controlling role of calcium.

Authors:  C B Wollheim; B Blondel; A E Renold; G W Sharp
Journal:  Diabetologia       Date:  1976-07       Impact factor: 10.122

Review 2.  Pancreatic signals controlling food intake; insulin, glucagon and amylin.

Authors:  Stephen C Woods; Thomas A Lutz; Nori Geary; Wolfgang Langhans
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

Review 3.  Neural regulation of the endocrine pancreas.

Authors:  F C Brunicardi; D M Shavelle; D K Andersen
Journal:  Int J Pancreatol       Date:  1995-12

4.  Adrenergic modulation of pancreatic glucagon secretion in man.

Authors:  J E Gerich; M Langlois; C Noacco; V Schneider; P H Forsham
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

Review 5.  Neuropeptidergic versus cholinergic and adrenergic regulation of islet hormone secretion.

Authors:  B Ahrén; G J Taborsky; D Porte
Journal:  Diabetologia       Date:  1986-12       Impact factor: 10.122

Review 6.  The physiology of glucagon.

Authors:  Gerald J Taborsky
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

7.  Fuels, hormones, and liver metabolism at term and during the early postnatal period in the rat.

Authors:  J R Girard; G S Cuendet; E B Marliss; A Kervran; M Rieutort; R Assan
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

8.  Extrapancreatic glucagon and glucagonlike immunoreactivity in depancreatized dogs. A quantitative assessment of secretion rates and anatomical delineation of sources.

Authors:  W A Muller; L Girardier; J Seydoux; M Berger; A E Renold; M Vranic
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

9.  Pancreatic noradrenergic nerves are activated by neuroglucopenia but not by hypotension or hypoxia in the dog. Evidence for stress-specific and regionally selective activation of the sympathetic nervous system.

Authors:  P J Havel; R C Veith; B E Dunning; G J Taborsky
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

10.  Acute parathyroid hormone response to epinephrine in vivo.

Authors:  J A Fischer; J W Blum; U Binswanger
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.